|
source DB |
source ID
|
text
|
size
|
updated at |
|
# proj.
|
|
# Ann.
|
updated_at |
| PubMed |
32171740 |
New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-1 |
1.18 KB |
2020-04-01 |
|
17 |
|
1 |
2021-01-18
|
| PubMed |
32150618 |
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the |
1.83 KB |
2020-04-01 |
|
34 |
|
2 |
2021-01-18
|
| PubMed |
32147496 |
Of chloroquine and COVID-19.
Recent publications have brought attention to the possible benefit of c |
374 Bytes |
2020-03-31 |
|
15 |
|
0 |
2021-01-18
|
| PubMed |
32196083 |
COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and p |
1.12 KB |
2020-04-02 |
|
16 |
|
2 |
2021-01-18
|
| PubMed |
32205204 |
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomi |
1.54 KB |
2020-03-31 |
|
11 |
|
2 |
2021-01-18
|
| PubMed |
32214286 |
Expanded Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) as a Therapeutic Strategy in Managing Criti |
3.68 KB |
2020-04-02 |
|
34 |
|
7 |
2021-01-18
|
| PubMed |
32222713 |
A Case of Novel Coronavirus Disease 19 in a Chronic Hemodialysis Patient Presenting with Gastroenter |
1.84 KB |
2020-04-08 |
|
13 |
|
12 |
2021-01-18
|
| PubMed |
32222466 |
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 ( |
1.06 KB |
2020-04-08 |
|
13 |
|
0 |
2021-01-18
|
| PubMed |
32251731 |
Structural and molecular modeling studies reveal a new mechanism of action of chloroquine and hydrox |
1.72 KB |
2020-04-08 |
|
10 |
|
0 |
2021-01-18
|
| PubMed |
32249257 |
Macrolide treatment for COVID-19: Will this be the way forward?
The severe acute respiratory syndrom |
960 Bytes |
2020-04-08 |
|
32 |
|
0 |
2021-01-18
|
